Home › Kindred Bio And X-Body Announce An Exclusive Collaboration For Discovery Of Antibodies For Companion Animal Health
 

Keywords :   


Kindred Bio And X-Body Announce An Exclusive Collaboration For Discovery Of Antibodies For Companion Animal Health

2014-04-02 04:17:44| drugdiscoveryonline News Articles

Kindred Biosciences, Inc. (NASDAQ: KIN) and X-Body Biosciences (X-Body) jointly announced today an exclusive alliance in which X-Body will discover fully canine, feline, and equine antibodies for companion animal health, and Kindred Bio will develop and commercialize these antibodies

Tags: health exclusive animal bio

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »